What is NDC 27241-155?

27241-155 is the product NDC for Oxybutynin Chloride, Oxybutynin chloride 5 mg/1 tablet, extended release, listed with the FDA by Ajanta Pharma USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Oxybutynin Chloride?

79 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Oxybutynin Chloride NDC 27241-155 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-155Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0155Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-155-04	2724101550427241015504	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-155-04)Marketed from Feb 28, 2019
27241-155-08	2724101550827241015508	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-155-08)Marketed from Feb 28, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxybutynin Chloride
Generic name (nonproprietary): oxybutynin chloride
Active ingredients: Oxybutynin chloride — 5 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Ajanta Pharma USA Inc.NDC labeler code 27241
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211655
Marketing start: Feb 28, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 27241-155_7513158b-c4a4-4e1a-b329-55ee91c5569eSPL ID 7513158b-c4a4-4e1a-b329-55ee91c5569eSPL set ID 95c2a144-ba0d-4011-ae0f-0e0ca876e8a8RxCUI 863619, 863628, 863636UNII L9F3D9RENQUPC 0327241156045, 0327241155048, 0327241157042
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241015504 followed by a unit qualifier and the quantity

Package 27241-0155-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 30, 2025.

Indications (excerpt from the label)

Oxybutynin chloride is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets is also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). Oxybutynin chloride is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ( 1 ) Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symp…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 27241-155

What is NDC 27241-155?: 27241-155 is the product NDC for Oxybutynin Chloride, Oxybutynin chloride 5 mg/1 tablet, extended release, listed with the FDA by Ajanta Pharma USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Oxybutynin Chloride.
What is the active ingredient?: Oxybutynin chloride.
Who is the labeler?: Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Oxybutynin Chloride?: 79 other product NDCs are listed under this name. See all Oxybutynin Chloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Oxybutynin Chloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Oxybutynin Chloride	Oxybutynin chloride 2.5 mg/1	TabletOral	TruPharma LLC	52817-261	52817-0261-10
Oxybutynin Chloride	Oxybutynin chloride 2.5 mg/1	TabletOral	RISING PHARMA HOLDINGS, INC.	64980-734	64980-0734-01
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	TabletOral	Coupler LLC	67046-1381	67046-1381-03
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-913	23155-0913-0123155-0913-0523155-0913-10
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	TabletOral	RISING PHARMA HOLDINGS, INC.	64980-679	64980-0679-0164980-0679-1064980-0679-50
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	TabletOral	A-S Medication Solutions	50090-8078	50090-8078-0050090-8078-0150090-8078-03
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	TabletOral	American Health Packaging	60687-899	60687-0899-01
Oxybutynin Chloride	Oxybutynin chloride 2.5 mg/1	TabletOral	Strides Pharma Science Limited	64380-190	64380-0190-01
Oxybutynin Chloride	Oxybutynin chloride 15 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1600	67046-1600-03
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1599	67046-1599-03

All 80 Oxybutynin Chloride NDCs

Other NDCs under ANDA 211655

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211655
Product	Strength	Form · route	Labeler	Product NDC
Oxybutynin Chloride	Oxybutynin chloride 10 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-156
Oxybutynin Chloride	Oxybutynin chloride 15 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-157
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1599
Oxybutynin Chloride	Oxybutynin chloride 15 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1600
Oxybutynin Chloride	Oxybutynin chloride 10 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-1690